Internal Medicine, Infectious Disease · Worcester, MA
NPI
1023364130
Since 2012
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
119 Belmont St
Worcester, MA, 01605
Phone (508) 334-6053
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
360 services
Medicare patients, 2024
257
Average age 71
Drug cost, 2024
$1.8M
841 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sami Arnaout was code 99222 (hospital e&m - initial), 144 times for 131 patients. In total Sami Arnaout billed 360 services in 15 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99222 Hospital E&M - Initial | Facility | 144 | 131 | $101.56 | $15K |
| 99223 Hospital E&M - Initial | Facility | 67 | 60 | $136.23 | $9,128 |
| 99213 Office E&M - Established | Office | 23 | 17 | $49.71 | $1,143 |
| 99232 Hospital E&M - Subsequent | Facility | 23 | 20 | $58.20 | $1,339 |
| 99214 Office E&M - Established | Office | 20 | 15 | $78.05 | $1,561 |
| 99213 Office E&M - Established | Facility | 18 | 15 | $41.44 | $746 |
By year: 2022 $27K for 330 services; 2023 $36K for 383 services; 2024 $33K for 360 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sami Arnaout prescribed most often to Medicare patients was Genvoya (Elviteg/Cob/Emtri/Tenof Alafen), with 73 prescriptions and refills. In total Sami Arnaout wrote 841 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 73 | 73 | Under 11 | $296K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 73 | 73 | Under 11 | $288K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 51 | 53 | Under 11 | $292 |
| Descovy Emtricitabine/Tenofov Alafenam | 49 | 49 | Under 11 | $106K |
| Juluca Dolutegravir/Rilpivirine | 47 | 47 | Under 11 | $174K |
| Isentress Raltegravir Potassium | 45 | 57 | Under 11 | $107K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 39 | 41 | Under 11 | $151K |
| Darunavir Generic | 28 | 28 | Under 11 | $31K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 26 | 34 | Under 11 | $166K |
| Ethambutol Hcl Generic | 24 | 31 | Under 11 | $644 |
| Azithromycin Generic | 24 | 29 | Under 11 | $168 |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 24 | 24 | Under 11 | $4,361 |
| Rifampin Generic | 22 | 29 | Under 11 | $384 |
| Valacyclovir Valacyclovir Hcl | 21 | 35 | Under 11 | $2,661 |
| Truvada Emtricitabine/Tenofovir (Tdf) | 21 | 23 | Under 11 | $40K |
Brand drugs: 459 claims; generic drugs: 382 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Sami Arnaout were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.